NextCure (NXTC)
(Delayed Data from NSDQ)
$1.60 USD
-0.03 (-1.84%)
Updated Jul 23, 2024 04:00 PM ET
After-Market: $1.64 +0.04 (2.50%) 7:58 PM ET
3-Hold of 5 3
D Value D Growth D Momentum F VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 8/1/24 |
---|---|
Current Quarter | -0.36 |
EPS Last Quarter | -0.61 |
Last EPS Surprise | -35.56% |
ABR | 1.75 |
Earnings ESP
|
0.00% |
---|---|
Current Year | -1.71 |
Next Year | -1.64 |
EPS (TTM) | -2.28 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | NA | NA | NA | NA |
# of Estimates | NA | NA | NA | NA |
High Estimate | NA | NA | NA | NA |
Low Estimate | NA | NA | NA | NA |
Year ago Sales | 0.00M | 0.00M | NA | NA |
Year over Year Growth Est. | NA | NA | NA | NA |
Earnings Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.36 | -0.35 | -1.71 | -1.64 |
# of Estimates | 2 | 2 | 3 | 3 |
Most Recent Consensus | -0.38 | -0.37 | -1.74 | -2.03 |
High Estimate | -0.34 | -0.32 | -1.62 | -1.41 |
Low Estimate | -0.38 | -0.37 | -1.78 | -2.03 |
Year ago EPS | -0.64 | -0.51 | -2.25 | -1.71 |
Year over Year Growth Est. | 43.75% | 31.37% | 24.00% | 4.09% |
Agreement - Estimate Revisions
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 0 | 0 |
Up Last 60 Days | 0 | 0 | 0 | 0 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 0 | 0 |
Down Last 60 Days | 0 | 0 | 0 | 0 |
Magnitude - Consensus Estimate Trend
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.36 | -0.35 | -1.71 | -1.64 |
7 Days Ago | -0.36 | -0.35 | -1.71 | -1.64 |
30 Days Ago | -0.36 | -0.35 | -1.71 | -1.64 |
60 Days Ago | -0.36 | -0.35 | -1.71 | -1.64 |
90 Days Ago | -0.40 | -0.36 | -1.65 | -1.62 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.36 | -0.35 | -1.71 | -1.64 |
Zacks Consensus Estimate | -0.36 | -0.35 | -1.71 | -1.64 |
Earnings ESP | 0.00% | 0.00% | 0.00% | 0.00% |
Surprise - Reported Earnings History
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.61 | -0.52 | -0.51 | -0.64 | NA |
Estimate | -0.45 | -0.54 | -0.64 | -0.60 | NA |
Difference | -0.16 | 0.02 | 0.13 | -0.04 | -0.01 |
Surprise | -35.56% | 3.70% | 20.31% | -6.67% | -4.56% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more